Skip to main content
Clinical Trials/NCT02891993
NCT02891993
Completed
N/A

Pilot Study of a Symptom Monitoring Intervention for Hospitalized Patients With Cancer

Massachusetts General Hospital1 site in 1 country150 target enrollmentSeptember 2016
ConditionsCancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
Massachusetts General Hospital
Enrollment
150
Locations
1
Primary Endpoint
Rates of participant completion of >2 symptom reports
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this research study is to address the challenge of symptom management for hospitalized patients with cancer.

Detailed Description

Patients with cancer may experience a considerable symptom burden, often requiring hospitalizations for symptom management. This study will pilot test an electronic symptom monitoring intervention, "Improving Management of Patient-Reported Outcomes Via Electronic Data (IMPROVED)," versus usual care in hospitalized patients with cancer. The goal of this study is test a model where patients' symptoms are monitored during their hospital admission electronically via tablet computers. The investigators are studying whether patients whose clinicians receive their patients' detailed symptom reports each day have improved symptom management compared to those whose clinicians do not receive their patients' detailed symptom reports each day. The study takes place at Massachusetts General Hospital and involves participating in a study for as long as the participants are admitted to the hospital. The information the investigators collect will help them determine if electronic symptom monitoring improves the care of patients with cancer.

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
December 14, 2017
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ryan Nipp

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Age 18 or older
  • Diagnosed with incurable cancer (defined as receiving treatment with palliative intent as per chemotherapy order entry designation, trial consent forms, or not receiving chemotherapy but followed for incurable disease as per oncology clinic notes)
  • Admitted to Lunder at Massachusetts General Hospital
  • Verbal fluency in English

Exclusion Criteria

  • Unwilling or unable to participate in the study
  • Admitted electively
  • Participated during a previous admission

Outcomes

Primary Outcomes

Rates of participant completion of >2 symptom reports

Time Frame: 2 years

To determine rates of participant completion of \>2 symptom reports, the investigators will assess the proportion of enrolled participants who complete of \>2 symptom reports.

Secondary Outcomes

  • Change In Patients' Symptom Scores(2 years)
  • Rates Of Depression Symptoms(2 years)
  • Change In Patients' Psychological Distress(2 years)
  • Change In Patients' Anxiety Scores(2 years)
  • Rates Of Clinicians Noting Their Patients' Symptom Reports(2 years)
  • Rates Of Clinicians Discussing Their Patients' Symptom Reports(2 years)
  • Change In Patients' Depression Scores(2 years)
  • Rates Of Moderate/Severe Symptoms(2 years)
  • Hospital Length Of Stay(2 years)
  • Rates Of Clinicians Developing An Action Plan In Response To Their Patients' Symptom Reports(2 years)
  • Rates Of Anxiety Symptoms(2 years)
  • Rates Of Moderate/Severe Psychological Symptoms(2 years)
  • Rates Of Patient Satisfaction(2 years)
  • 30-Day Readmissions Rates(2 years)

Study Sites (1)

Loading locations...

Similar Trials